NOI - Insulated-Sensing Myocardial Navigation Guidewire, Initial R&D and In Vivo Test
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Heart, Lung, and Blood Institute (NHLBI) intends to award a sole source contract for the design, fabrication, and testing of insulated-sensing intramyocardial electrosurgical guidewire prototypes. This Notice of Intent (NOI) is for a translational research and development project to evaluate the engineering feasibility of a 0.014-inch guidewire for controlled myocardial tissue traversal, electrogram sensing, electroanatomic mapping, and radiofrequency ablation in a preclinical setting. While not a request for competitive proposals, interested parties may submit capability statements for consideration. The intended source is Resonetics.
Scope of Work
This effort includes:
- Developing mechanical and electrical design profiles for the guidewire.
- Designing and implementing insulation strategies for electrosurgery and electrogram sensing.
- Fabricating initial prototype variants for bench evaluation.
- Performing mechanical and electrical validation testing.
- Iterating design based on test results and government feedback.
- Fabricating and delivering approximately 10-20 refined prototypes for in vivo animal laboratory evaluation.
- Providing technical support during evaluation and incorporating feedback into final documentation.
Contract & Timeline
- Contract Type: Sole Source (Presolicitation)
- Procedure: FAR Part 13 – Simplified Acquisition Procedures
- Period of Performance: Date of Award through approximately 15 weeks thereafter.
- Delivery: Approximately 10-15 weeks after contract award.
- Response Due: April 28, 2026, at 1:00 pm EDT
- Published: April 16, 2026
Eligibility / Set-Aside
- NAICS Code: 541714 – Research and Development in Biotechnology (except Nanobiotechnology)
- Size Standard: 1,000 employees
- Set-Aside: This acquisition is NOT set aside for small business.
Submission & Evaluation
This is not a request for competitive proposals. However, responsible sources may submit a capability statement, proposal, or quotation. Responses must include sufficient detail, pricing information, delivery terms, business size status, and SAM registration. Submissions should be sent electronically to nicholas.capobianco@nih.gov. A determination not to compete is at the Government's discretion, as an award to any other source would result in substantial duplication of cost and unacceptable delays.